The choice of docking algorithm is critical in computational biology since it has a substantial impact on the accuracy of predicting molecular interactions. Docking algorithms mimic chemical binding, assisting in drug development and understanding biological processes. The presence of decoys, molecules that imitate real binders but provide deceptive outcomes, creates a problem. Decoys can mislead researchers by providing false positives, therefore retrieval of trustworthy decoy datasets and metrics for evaluating algorithm performance is critical. Computational biologists could enhance the precision and dependability of their predictions by carefully selecting and fine-tuning docking methods, thus improving our knowledge of complicated biological systems in drug development. In this work, data mining was used to identify key biological targets against a disease model, as well as beneficial small molecular decoy compounds for specific protein targets based on their reported bioactivity using an in-house script. Enrichment analysis was used to pick the best potential molecular interaction setup.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Selecting Optimal Molecular Interaction Settings and Identifying Key Biological Targets Through Enrichment Analysis and Data Mining

  • Rik Ganguly,
  • Rajat Roy,
  • Atanu Bhattacharjee

摘要

The choice of docking algorithm is critical in computational biology since it has a substantial impact on the accuracy of predicting molecular interactions. Docking algorithms mimic chemical binding, assisting in drug development and understanding biological processes. The presence of decoys, molecules that imitate real binders but provide deceptive outcomes, creates a problem. Decoys can mislead researchers by providing false positives, therefore retrieval of trustworthy decoy datasets and metrics for evaluating algorithm performance is critical. Computational biologists could enhance the precision and dependability of their predictions by carefully selecting and fine-tuning docking methods, thus improving our knowledge of complicated biological systems in drug development. In this work, data mining was used to identify key biological targets against a disease model, as well as beneficial small molecular decoy compounds for specific protein targets based on their reported bioactivity using an in-house script. Enrichment analysis was used to pick the best potential molecular interaction setup.